Basilea Pharmaceutica AG (SWX:BSLN)

Basilea Pharmaceutica AG Revenue

In the year 2025, Basilea Pharmaceutica AG had annual revenue of 232.38M CHF with 11.43% growth. Basilea Pharmaceutica AG had revenue of 128.42M in the half year ending December 31, 2025, with 76.57% growth.

• Revenue: 232.38M
• Revenue Growth: +11.43%
• P/S Ratio: 2.77
• Revenue / Employee: 1.23M
• Employees: 189
• Market Cap: 643.35M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	232.38M	23.84M	11.43%
Dec 31, 2024	208.54M	50.91M	32.30%
Dec 31, 2023	157.63M	9.87M	6.68%
Dec 31, 2022	147.77M	-357.00K	-0.24%
Dec 31, 2021	148.12M	20.49M	16.06%
Dec 31, 2020	127.63M	-6.75M	-5.02%
Dec 31, 2019	134.38M	1.83M	1.38%
Dec 31, 2018	132.56M	31.03M	30.57%
Dec 31, 2017	101.52M	35.54M	53.86%
Dec 31, 2016	65.98M	13.16M	24.91%
Dec 31, 2015	52.83M	10.19M	23.90%
Dec 31, 2014	42.63M	1.26M	3.04%
Dec 31, 2013	41.38M	-16.96M	-29.07%
Dec 31, 2012	58.34M	-8.51M	-12.73%
Dec 31, 2011	66.85M	-176.32M	-72.51%
Dec 31, 2010	243.17M	216.34M	806.40%
Dec 31, 2009	26.83M	14.85M	124.05%
Dec 31, 2008	11.97M	3.76M	45.82%
Dec 31, 2007	8.21M	-6.37M	-43.68%
Dec 31, 2006	14.58M	-15.91M	-52.18%
Dec 31, 2005	30.49M	-	-

Data Source: Fiscal.ai Last updated: Nov 14, 2025

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 2, 2026

Data Sources Report a data error